
Join to View Full Profile
10 Center Dr Msc 1868 NihBldg 10Bethesda, MD 20892
Phone+1 301-496-0328
Fax+1 301-480-5955
Are you Dr. Yarchoan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 9 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Robert Yarchoan, MD is an allergist/immunologist in Bethesda, Maryland. He is currently licensed to practice medicine in Maryland and Minnesota.
Education & Training
- Perelman School of Medicine at the University of PennsylvaniaClass of 1975
Certifications & Licensure
- MD State Medical License 1978 - 2025
- MN State Medical License 1976 - 2023
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1993
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer Start of enrollment: 2000 Dec 06
- Assessment of Blood Vessel Density in Kaposi's Sarcoma Lesions Start of enrollment: 2001 Apr 23
- Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity Start of enrollment: 2004 Oct 28
- Join now to see all
Publications & Presentations
PubMed
- The elevated expression of ORF75, a KSHV lytic gene, in Kaposi sarcoma lesions is driven by a GC-rich DNA cis element in its promoter region.Ashwin Nair, David A Davis, Andrew Warner, Baktiar Karim, Ramya Ramaswami
Plos Pathogens. 2025-03-17 - Primary Effusion Lymphoma Prognostic Score (PEL-PS): A Validated International Prognostic Score in HIV-Associated Primary Effusion Lymphoma.Kathryn Lurain, Ramya Ramaswami, Eric Oksenhendler, David Boutboul, Alessia Dalla Pria
American Journal of Hematology. 2025-03-01 - Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma.Ramya Ramaswami, Angela Shaulov Kask, Leonard D'Amico, Manoj P Menon, Kathryn Lurain
Journal for Immunotherapy of Cancer. 2025-02-06
Press Mentions
- HIV-Associated Cancers: A Paradigm Shift?April 19th, 2018
Grant Support
- Development Of Novel Therapies For HIV InfectionNational Cancer Institute2008
- Clinical Trials Of Patients With Aids-Related MalignanciesNational Cancer Institute2008
- Pediatric Hivaids Clinical ResearchNational Cancer Institute2007–2008
- Development Of Novel Therapies For HIV Infection And Aids-Related MalignanciesNational Cancer Institute2007
- Pediatric Hivaids Clinical ResearchDivision Of Clinical Sciences - Nci2005–2006
- Development Of Novel Therapies For HIV Infection And AIDDivision Of Clinical Sciences - Nci2002–2006
- Novel Therapies For HIV Inf. &Aids-Related MalignanciesDivision Of Clinical Sciences - Nci2004
- Pediatric HIV/AIDS Clinical ResearchDivision Of Clinical Sciences - Nci1999–2004
- Development Of Novel Therapies For HIV Infection And RELDivision Of Clinical Sciences - Nci2001
- Development Of Novel Therapies For HIV Infection And Related MalignanciesDivision Of Clinical Sciences - Nci1997–2000
- Development Of Novel Therapies For HIV Infection &Related MalignanciesDivision Of Clinical Sciences - Nci1996
- Study of and development of antiviral drugs against SARS-CoV2 proteaseDIVISION OF BASIC SCIENCES - NCIPresent
- Study of and development of antiviral drugs against SARS-CoV2 proteaseDIVISION OF BASIC SCIENCES - NCIPresent
- Study of Tumor Pathogenesis and Development of Therapies for AIDS MalignanciesDIVISION OF BASIC SCIENCES - NCIPresent
- Development of Preventive Strategies and Therapy for HIV InfectionDIVISION OF CLINICAL SCIENCES - NCIPresent
- Clinical Trials of Patients with AIDS-Related MalignanciesDIVISION OF BASIC SCIENCES - NCIPresent
- Development of Preventive Strategies and Therapy for HIV InfectionDIVISION OF CLINICAL SCIENCES - NCIPresent
- Study of Tumor Pathogenesis and Development of Therapies for AIDS MalignanciesDIVISION OF BASIC SCIENCES - NCIPresent
- Clinical Trials of Patients with AIDS-Related MalignanciesDIVISION OF BASIC SCIENCES - NCIPresent